Abstract
Exposure-Response Relationship of the SMART-Ig Anti-hC5 Antibody Crovalimab (SKY59): Results from the Umbrella Phase 1/2 Composer Trial in Healthy Volunteers and PNH Patients
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have